Ligand ID: 2FA


Drugbank ID:
DB01073
(Fludarabine)


Indication:
For the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen

Get human targets for 2FA in PDB (known and potential targets)

RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES MAPPED TO LIGAND '2FA' AND SARS-COV-2 / COVID-19 STRUCTURES

1) User may click on the DrReposER ID (the first column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera throuh AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 View Interface RMSD Seq.
Identity (%)		 HETATM Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
HIS A  41
LEU A  27
GLY A 146
HIS A 163
PHE A 181
1.79A14.75
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
LEU A 205
VAL A 296
LEU A 250
ASN A 214
GLY A 215
1.67A18.13
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 4
ALA A 206
VAL A 261
GLY A 258
THR A 257
1.73A18.40
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 5
GLN A 110
THR A 111
THR A 201
LEU A 250
1.44A14.75
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6lxt SPIKE PROTEIN S2
(SARS-CoV-2)		5 / 12
LEU E1186
GLY D 946
THR E 941
LEU E 945
ASN D1187
1.20A15.17
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6lze VIRAL PROTEASE
(SARS-CoV-2)		4 / 4
ALA A 206
VAL A 261
GLY A 258
THR A 257
1.76A23.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6lze VIRAL PROTEASE
(SARS-CoV-2)		4 / 5
GLN A 110
THR A 111
THR A 201
LEU A 250
1.39A20.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6lze VIRAL PROTEASE
(SARS-CoV-2)		5 / 12
ASP A 216
GLY A 283
LEU A 287
ASN A 214
GLY A   2
1.66A19.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)		6lze VIRAL PROTEASE
(SARS-CoV-2)		5 / 12
HIS A  41
LEU A  27
GLY A 146
HIS A 163
PHE A 181
1.79A20.00
ALC  D   2 ( 4.1A)
None
None
ELL  D   3 (-3.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6lze VIRAL PROTEASE
(SARS-CoV-2)		5 / 12
LEU A 205
VAL A 296
LEU A 250
ASN A 214
GLY A 215
1.64A19.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_1
(ADENOSINE KINASE)		6m0j ACE2
SPIKE RECEPTOR
BINDING DOMAIN
(Homo
sapiens;
SARS-CoV-2)		5 / 12
GLY E 502
GLY A 354
PHE A 356
ALA A 387
ASP E 405
1.72A21.05
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6m0k VIRAL PROTEASE
(SARS-CoV-2)		4 / 4
ALA A 206
VAL A 261
GLY A 258
THR A 257
1.76A23.71
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6m0k VIRAL PROTEASE
(SARS-CoV-2)		5 / 12
LEU A 205
VAL A 296
LEU A 250
ASN A 214
GLY A 215
1.64A19.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6m0k VIRAL PROTEASE
(SARS-CoV-2)		4 / 5
GLN A 110
THR A 111
THR A 201
LEU A 250
1.53A19.96
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)		6m0k VIRAL PROTEASE
(SARS-CoV-2)		5 / 12
HIS A  41
LEU A  27
GLY A 146
HIS A 163
PHE A 181
1.80A19.96
N0A  D   2 ( 4.0A)
None
None
ELL  D   3 (-3.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6m0k VIRAL PROTEASE
(SARS-CoV-2)		5 / 12
ASP A 216
GLY A 283
LEU A 287
ASN A 214
GLY A   2
1.67A19.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 12
GLY A   2
ASN A 214
VAL C 171
GLY A 215
ASP A 216
1.63A19.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 12
GLY D   2
GLY B 138
THR B 169
LEU B 167
GLY D 283
1.64A19.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		4 / 5
GLN C 110
THR C 111
THR C 201
LEU C 250
1.24A19.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 12
HIS C  41
LEU C  27
GLY C 146
HIS C 163
PHE C 181
1.78A19.88
3WL  C 401 (-3.4A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 12
LEU B 205
VAL B 296
LEU B 250
ASN B 214
GLY B 215
1.57A19.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		4 / 5
GLN A 110
THR A 111
THR A 201
LEU A 250
1.33A19.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 12
LEU A 205
VAL A 296
LEU A 250
ASN A 214
GLY A 215
1.58A19.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		4 / 4
ALA D 206
VAL D 261
GLY D 258
THR D 257
1.75A23.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 12
LEU C 205
VAL C 296
LEU C 250
ASN C 214
GLY C 215
1.63A19.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		4 / 5
GLN D 110
THR D 111
THR D 201
LEU D 250
1.30A19.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 12
GLY C   2
GLY A 138
THR A 169
LEU A 167
GLY C 283
1.62A19.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 12
HIS D  41
LEU D  27
GLY D 146
HIS D 163
PHE D 181
1.80A19.88
3WL  D 401 (-3.9A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		4 / 5
GLN B 110
THR B 111
THR B 201
LEU B 250
1.31A19.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		4 / 4
ALA C 206
VAL C 261
GLY C 258
THR C 257
1.67A23.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 12
LEU D  32
GLY D 174
VAL D  86
LEU D  30
ASN D 180
1.67A19.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		4 / 4
ALA B 206
VAL B 261
GLY B 258
THR B 257
1.74A23.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		4 / 4
ALA A 206
VAL A 261
GLY A 258
THR A 257
1.75A23.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6m2q 3CL PROTEASE
(SARS-CoV-2)		5 / 12
LEU A 205
VAL A 296
LEU A 250
ASN A 214
GLY A 215
1.65A19.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6m2q 3CL PROTEASE
(SARS-CoV-2)		5 / 12
ASP A 216
GLY A 283
LEU A 287
ASN A 214
GLY A   2
1.66A19.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6m2q 3CL PROTEASE
(SARS-CoV-2)		4 / 4
ALA A 206
VAL A 261
GLY A 258
THR A 257
1.76A23.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6m2q 3CL PROTEASE
(SARS-CoV-2)		4 / 5
GLN A 110
THR A 111
THR A 201
LEU A 250
1.22A19.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6m3m NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 5
LEU B 168
GLN B 161
THR B  58
HIS B  60
1.60A16.20
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_A_2FAA301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		6m71 NSP12
(SARS-CoV-2)		5 / 11
MET A 666
SER A 343
GLY A 345
VAL A 535
VAL A 354
1.57A13.84
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_1
(ADENOSINE KINASE)		6m71 NSP12
(SARS-CoV-2)		5 / 12
GLY A 671
GLY A 670
PHE A 407
ALA A 449
ASP A 390
1.79A16.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6m71 NSP12
(SARS-CoV-2)		5 / 12
GLY A 352
ASN A 314
VAL A 354
LEU A 329
ASN A 300
1.63A17.65
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6m71 NSP12
(SARS-CoV-2)		5 / 12
LEU A 727
GLY A 712
ASN A 713
LEU A 707
ASN A  39
1.67A17.65
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6m71 NSP12
NSP8
(SARS-CoV-2)		5 / 12
LEU A 366
VAL A 373
LEU B  91
ASN A 356
GLY A 345
1.66A17.65
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_2
(ADENOSINE KINASE)		6m71 NSP12
(SARS-CoV-2)		4 / 5
LEU A 514
ALA A 502
MET A 519
PHE A 506
1.51A17.65
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_2
(ADENOSINE KINASE)		6m71 NSP7
(SARS-CoV-2)		4 / 4
ALA C  48
VAL C  53
PHE C  49
THR C   9
1.65A11.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6m71 NSP12
(SARS-CoV-2)		4 / 5
GLN A 210
THR A 123
THR A 148
LEU A 178
1.77A20.59
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_A_2FAA306_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 10
ARG B1019
GLY B 769
VAL B 772
GLU B 773
GLU A1017
1.79A12.09
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 5
LEU B 962
GLN B 957
THR B 961
THR B 734
1.56A17.53
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_C_2FAC308_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 11
ARG B1019
GLY B 769
VAL B 772
GLU B 773
GLU A1017
1.74A12.09
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 4
ALA A 647
VAL A 615
GLY A 593
THR B 859
1.49A15.30
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_2
(ADENOSINE KINASE)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 5
LEU C 611
ILE C 670
ALA C 653
PHE C 643
1.34A14.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		6 / 12
GLY C 593
GLY C 594
ASN C 317
LEU C 611
GLY A 857
ASP A 737
1.74A14.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_D_2FAD500_2
(ADENOSYLHOMOCYSTEINA
SE)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 4
LEU B 962
GLN B 957
THR B 961
THR B 734
1.65A17.53
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_1
(ADENOSINE KINASE)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
GLY A 799
GLY A 798
PHE A 797
PHE A 898
GLN A 901
1.59A15.30
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_A_2FAA301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 11
ARG C1019
GLY C 769
VAL C 772
GLU C 773
GLU B1017
1.77A12.13
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_B_2FAB301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
HIS A1064
ARG C1039
SER A1037
GLY A1035
GLU A1031
1.79A12.13
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_1
(ADENOSINE KINASE)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
GLY C 593
GLY C 594
ASN C 317
GLY A 857
ASP A 737
1.32A15.30
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6vxs NSP3
(SARS-CoV-2)		5 / 12
ASN B  37
LEU B  75
GLY B  47
LEU B  43
GLY B 130
1.70A
None
SO4  B 201 ( 4.4A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6vxs NSP3
(SARS-CoV-2)		5 / 12
ASN A  37
LEU A  75
GLY A  47
LEU A  43
GLY A 130
1.64A
None
SO4  A 201 (-4.1A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6vxs NSP3
(SARS-CoV-2)		5 / 12
ASN A  37
LEU A  75
GLY A  48
LEU A  43
GLY A 130
1.71A
None
SO4  A 201 (-4.1A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_A_2FAA301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 11
ARG B1019
GLY B 769
VAL B 772
GLU B 773
GLU A1017
1.76A11.94
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_1
(ADENOSINE KINASE)		6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
GLY B 799
GLY B 798
PHE B 797
PHE B 898
GLN B 901
1.71A15.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_C_2FAC308_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 11
SER C  31
GLY C 268
VAL C 267
GLU C 191
SER C  60
1.53A12.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_A_2FAA306_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 10
SER C  31
GLY C 268
VAL C 267
GLU C 191
SER C  60
1.52A12.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 4
ALA A 930
VAL A1065
GLY A1044
THR A 723
1.54A15.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z35_A_2FAA300_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 10
THR B 719
GLY B1046
THR C 887
GLU B1072
SER B 721
1.77A11.07
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_2
(ADENOSINE KINASE)		6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 5
LEU B 878
ALA B 876
MET B1029
PHE B 888
1.58A15.01
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
GLY A 593
GLY A 594
ASN A 317
GLY B 857
ASP B 737
1.28A15.01
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_C_2FAC308_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 11
SER A  31
GLY A 268
VAL A 267
GLU A 191
SER A  60
1.43A12.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z35_A_2FAA300_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 10
ARG A1019
GLY A 769
VAL A 772
GLU A 773
GLU C1017
1.67A11.07
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_A_2FAA306_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 10
SER A  31
GLY A 268
VAL A 267
GLU A 191
SER A  60
1.43A12.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_A_2FAA301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 11
SER A  31
GLY A 268
VAL A 267
GLU A 191
SER A  60
1.57A11.94
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_2
(ADENOSINE KINASE)		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 5
LEU B 878
ALA B 876
MET B1029
PHE B 888
1.52A15.01
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_B_2FAB301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
SER A  31
GLY A 268
VAL A 267
GLU A 191
SER A  60
1.65A11.94
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_1
(ADENOSINE KINASE)		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
GLY A 799
GLY A 798
PHE A 797
PHE A 898
GLN A 901
1.68A15.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_1
(ADENOSINE KINASE)		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
GLY A 593
GLY A 594
ASN A 317
GLY B 857
ASP B 737
1.34A15.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 4
ALA B 930
VAL B1065
GLY B1044
THR B 723
1.42A15.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_1
(ADENOSINE KINASE)		6vyo NUCLEOPROTEIN
(SARS-CoV-2)		5 / 12
ASP C  98
GLY C  99
GLY C  97
ALA D 119
ASP D 144
1.40A17.31
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_1
(ADENOSINE KINASE)		6vyo NUCLEOPROTEIN
(SARS-CoV-2)		5 / 12
ASP C  98
GLY C  99
GLY C  97
ALA D 119
ASP D 144
1.41A17.31
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6vyo NUCLEOPROTEIN
(SARS-CoV-2)		4 / 5
LEU D 167
GLN D 160
THR D  57
HIS D  59
1.49A13.93
None
None
None
ZN  A 204 ( 3.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_D_2FAD500_1
(ADENOSYLHOMOCYSTEINA
SE)		6vyo NUCLEOPROTEIN
(SARS-CoV-2)		5 / 12
THR D 115
ASP D  82
HIS C  59
GLY D 147
PHE D 110
1.77A13.93
None
ZN  D 201 ( 2.4A)
ZN  D 201 ( 3.3A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_2
(ADENOSINE KINASE)		6w41 SPIKE PROTEIN S1
(SARS-CoV-2)		4 / 5
LEU C 387
ILE C 358
ALA C 363
PHE C 338
1.60A17.98
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w4h NSP10
(SARS-CoV-2)		4 / 5
GLN B4306
THR B4309
THR B4300
HIS B4301
1.62A13.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w4h NSP16
(SARS-CoV-2)		4 / 5
LEU A6887
THR A6891
THR A6880
HIS A6867
1.62A20.61
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6w4h NSP10
NSP16
(SARS-CoV-2)		4 / 4
ALA B4324
VAL A6876
GLY A6879
THR A6880
1.22A18.44
None
None
SAM  A7102 (-3.4A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_1
(ADENOSINE KINASE)		6w4h NSP16
(SARS-CoV-2)		5 / 12
SER A6964
GLY A6962
GLY A6963
ASN A7008
GLY A7076
1.64A20.93
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6w61 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		4 / 4
ALA B4324
VAL A6876
GLY A6879
THR A6880
1.22A
None
None
SAM  A7104 (-3.6A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w61 NSP10
(SARS-CoV-2)		4 / 5
GLN B4306
THR B4309
THR B4300
HIS B4301
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w61 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		4 / 5
LEU B4298
GLN A6850
THR A6846
HIS B4301
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 5
LEU A6887
THR A6891
THR A6880
HIS A6867
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w61 NSP10
(SARS-CoV-2)		4 / 5
GLN B4306
THR B4309
THR B4300
HIS B4301
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
LEU A6887
GLY A6962
GLY A6963
ASN A7008
GLY A7076
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_1
(ADENOSINE KINASE)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
SER A6964
GLY A6962
GLY A6963
ASN A7008
GLY A7076
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 5
LEU A6887
THR A6891
THR A6880
HIS A6867
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
LEU A6887
ASN A6920
THR A6891
LEU A6893
ASN A7083
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 5
GLN A6847
THR A6993
HIS A6867
LEU A6883
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_1
(ADENOSYLHOMOCYSTEINA
SE)		6w63 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
HIS A  41
LEU A  27
GLY A 146
HIS A 163
PHE A 181
1.78A19.88
X77  A 401 (-3.2A)
X77  A 401 ( 3.9A)
None
X77  A 401 (-4.1A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)		6w63 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
HIS A  41
LEU A  27
GLY A 146
HIS A 163
PHE A 181
1.67A19.88
X77  A 401 (-3.2A)
X77  A 401 ( 3.9A)
None
X77  A 401 (-4.1A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w63 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 5
GLN A 110
THR A 111
THR A 201
LEU A 250
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6w63 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 4
ALA A 206
VAL A 261
GLY A 258
THR A 257
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6w6y NSP3
(SARS-CoV-2)		5 / 12
LEU A 164
GLY A 133
ASN A  99
LEU A 160
GLY A  97
1.79A19.78
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6w6y NSP3
(SARS-CoV-2)		5 / 12
ASN A  37
LEU A  75
GLY A  47
LEU A  43
GLY A 130
1.70A
None
None
None
None
AMP  A 201 ( 3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w75 NSP10
NSP16
(SARS-CoV-2)		4 / 5
LEU B4298
GLN A6850
THR A6846
HIS B4301
1.68A13.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w75 NSP10
(SARS-CoV-2)		4 / 5
GLN B4306
THR B4309
THR B4300
HIS B4301
1.60A13.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
LEU C6887
GLY C6962
GLY C6963
ASN C7008
GLY C7076
1.62A19.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w75 NSP10
NSP16
(SARS-CoV-2)		4 / 5
LEU B4298
GLN A6850
THR A6846
HIS B4301
1.73A13.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_1
(ADENOSINE KINASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
SER A6964
GLY A6962
GLY A6963
ASN A7008
GLY A7076
1.66A16.41
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
LEU A6855
GLY A6963
THR A6856
LEU A6857
GLY A7011
1.75A19.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w75 NSP10
(SARS-CoV-2)		4 / 5
GLN D4306
THR D4309
THR D4300
HIS D4301
1.63A13.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6w75 NSP10
NSP16
(SARS-CoV-2)		4 / 4
ALA D4324
VAL C6876
GLY C6879
THR C6880
1.21A18.44
None
None
SAM  C7105 ( 3.4A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w75 NSP10
(SARS-CoV-2)		4 / 5
GLN D4306
THR D4309
THR D4300
HIS D4301
1.57A13.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w75 NSP10
NSP16
(SARS-CoV-2)		4 / 5
LEU D4298
GLN C6850
THR C6846
HIS D4301
1.66A13.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w75 NSP16
(SARS-CoV-2)		4 / 5
LEU A6887
THR A6891
THR A6880
HIS A6867
1.67A15.53
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w75 NSP16
(SARS-CoV-2)		4 / 5
GLN A6847
THR A6993
HIS A6867
LEU A6883
1.52A15.53
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6w75 NSP10
NSP16
(SARS-CoV-2)		4 / 4
ALA B4324
VAL A6876
GLY A6879
THR A6880
1.20A18.44
None
None
SAM  A7102 ( 3.4A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w75 NSP10
(SARS-CoV-2)		4 / 5
GLN B4306
THR B4309
THR B4300
HIS B4301
1.53A13.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
LEU C6909
ASN C6862
VAL A7094
ASN A7096
GLY C6890
1.65A19.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_1
(ADENOSINE KINASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
SER C6964
GLY C6962
GLY C6963
ASN C7008
GLY C7076
1.64A16.41
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w75 NSP10
(SARS-CoV-2)		4 / 5
GLN B4306
THR B4309
THR B4300
HIS B4301
1.57A13.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
LEU A6887
GLY A6962
GLY A6963
ASN A7008
GLY A7076
1.65A19.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w75 NSP16
(SARS-CoV-2)		4 / 5
LEU C6887
THR C6891
THR C6880
HIS C6867
1.62A15.53
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w75 NSP16
(SARS-CoV-2)		4 / 5
GLN C6847
THR C6993
HIS C6867
LEU C6883
1.51A15.53
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w75 NSP16
(SARS-CoV-2)		4 / 5
LEU C6887
THR C6891
THR C6880
HIS C6867
1.63A15.53
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		6w75 NSP16
(SARS-CoV-2)		4 / 5
LEU A6887
THR A6891
THR A6880
HIS A6867
1.68A15.53
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
ASN C6920
ASN C6862
VAL A7094
ASN A7096
GLY C6890
1.73A19.14
FMT  C7106 ( 4.1A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 12
LEU C 118
GLY C 163
VAL C 165
THR C 115
GLY C 271
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		6 / 12
ASP A 164
LEU A 118
GLY A 163
VAL A 165
THR A 115
GLY A 271
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 12
ASN B 110
LEU B 118
GLY B 163
VAL B 165
THR B 115
1.53A
None
None
None
None
CL  B 502 ( 4.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 12
ASN A 110
LEU A 118
VAL A 165
THR A 115
GLY A 266
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 12
ASN C 110
LEU C 118
GLY C 163
VAL C 165
THR C 115
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 12
LEU B 118
GLY B 163
VAL B 165
THR B 115
GLY B 271
1.47A
None
None
None
CL  B 502 ( 4.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 12
ASN B 110
LEU B 118
VAL B 165
THR B 115
GLY B 266
1.55A
None
None
None
CL  B 502 ( 4.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 12
ASN A 110
LEU A 118
GLY A 163
VAL A 165
THR A 115
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_2
(ADENOSINE KINASE)		6wiq NSP8
(SARS-CoV-2)		4 / 5
LEU B 128
ILE B 132
ALA B 188
PHE B 147
1.66A16.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wiq NSP7
NSP8
(SARS-CoV-2)		4 / 5
GLN B  88
THR B  89
THR A   9
LEU A  56
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_A_2FAA301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 11
GLY E 328
VAL E 324
GLU E 323
MET E 322
ASP F 341
1.45A20.83
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
ASN D 285
ASP D 288
LEU C 331
GLY D 287
GLY D 295
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS E 300
GLU E 290
ASP E 288
LEU E 352
HIS E 356
1.50A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
ASN C 285
ASP C 288
LEU D 331
GLY C 287
GLY C 295
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS A 300
GLU A 290
ASP A 288
LEU A 352
HIS A 356
1.59A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_D_2FAD500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS E 300
GLU E 290
ASP E 288
LEU E 352
HIS E 356
1.54A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_A_2FAA301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 11
GLY B 328
VAL B 324
GLU B 323
MET B 322
ASP A 341
1.53A20.83
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
ASN B 285
ASP B 288
LEU A 331
GLY B 287
GLY B 295
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_A_2FAA301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 11
GLY A 328
VAL A 324
GLU A 323
MET A 322
ASP B 341
1.28A20.83
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS D 300
GLU D 290
ASP D 288
LEU D 352
HIS D 356
1.51A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_B_2FAB301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
GLY B 328
VAL B 324
GLU B 323
MET B 322
ASP A 341
1.56A20.83
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS B 300
GLU B 290
ASP B 288
LEU B 352
HIS B 356
1.53A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_A_2FAA301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 11
GLY D 328
VAL D 324
GLU D 323
MET D 322
ASP C 341
1.53A20.83
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_2
(ADENOSINE KINASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 5
LEU D 331
ALA C 308
MET C 317
PHE D 314
1.67A15.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_D_2FAD500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS A 300
GLU A 290
ASP A 288
LEU A 352
HIS A 356
1.60A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_A_2FAA301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 11
GLY F 328
VAL F 324
GLU F 323
MET F 322
ASP E 341
1.51A20.83
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
ASN F 285
ASP F 288
LEU E 331
GLY F 287
GLY F 295
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_2
(ADENOSINE KINASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 5
LEU F 331
ALA E 308
MET E 317
PHE F 314
1.66A15.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
ASN E 285
ASP E 288
LEU F 331
GLY E 287
GLY E 295
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS C 300
GLU C 290
ASP C 288
LEU C 352
HIS C 356
1.61A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS E 300
GLU E 290
ASP E 288
LEU E 352
HIS E 356
1.49A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_B_2FAB301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
GLY F 328
VAL F 324
GLU F 323
MET F 322
ASP E 341
1.57A20.83
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_A_2FAA301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 11
GLY C 328
VAL C 324
GLU C 323
MET C 322
ASP D 341
1.48A20.83
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_A_2FAA306_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 10
GLY C 328
VAL C 324
GLU C 323
MET C 322
ASP D 341
1.64A18.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_2
(ADENOSINE KINASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 5
LEU B 331
ALA A 308
MET A 317
PHE B 314
1.73A15.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_A_2FAA306_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 10
GLY E 328
VAL E 324
GLU E 323
MET E 322
ASP F 341
1.54A18.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_2
(ADENOSINE KINASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 5
LEU A 331
ALA B 308
MET B 317
PHE A 314
1.66A15.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_A_2FAA306_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 10
GLY A 328
VAL A 324
GLU A 323
MET A 322
ASP B 341
1.40A18.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS D 300
GLU D 290
ASP D 288
LEU D 352
HIS D 356
1.49A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_B_2FAB301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
GLY C 328
VAL C 324
GLU C 323
MET C 322
ASP D 341
1.54A20.83
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_D_2FAD500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS D 300
GLU D 290
ASP D 288
LEU D 352
HIS D 356
1.53A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_D_2FAD500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS F 300
GLU F 290
ASP F 288
LEU F 352
HIS F 356
1.62A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_C_2FAC308_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 11
GLY E 328
VAL E 324
GLU E 323
MET E 322
ASP F 341
1.56A18.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_B_2FAB301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
GLY A 328
VAL A 324
GLU A 323
MET A 322
ASP B 341
1.33A20.83
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_2
(ADENOSINE KINASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 5
LEU C 331
ALA D 308
MET D 317
PHE C 314
1.70A15.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS F 300
GLU F 290
ASP F 288
LEU F 352
HIS F 356
1.61A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS D 300
GLU D 290
ASP D 288
LEU D 352
HIS D 356
1.50A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_B_2FAB301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
GLY E 328
VAL E 324
GLU E 323
MET E 322
ASP F 341
1.51A20.83
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS C 300
GLU C 290
ASP C 288
LEU C 352
HIS C 356
1.64A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS F 300
GLU F 290
ASP F 288
LEU F 352
HIS F 356
1.58A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS A 300
GLU A 290
ASP A 288
LEU A 352
HIS A 356
1.56A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS A 300
GLU A 290
ASP A 288
LEU A 352
HIS A 356
1.56A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_D_2FAD500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS B 300
GLU B 290
ASP B 288
LEU B 352
HIS B 356
1.54A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_B_2FAB301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
GLY D 328
VAL D 324
GLU D 323
MET D 322
ASP C 341
1.57A20.83
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS B 300
GLU B 290
ASP B 288
LEU B 352
HIS B 356
1.53A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS B 300
GLU B 290
ASP B 288
LEU B 352
HIS B 356
1.53A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS F 300
GLU F 290
ASP F 288
LEU F 352
HIS F 356
1.57A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
ASN A 285
ASP A 288
LEU B 331
GLY A 287
GLY A 295
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS E 300
GLU E 290
ASP E 288
LEU E 352
HIS E 356
1.52A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
HIS C 300
GLU C 290
ASP C 288
LEU C 352
HIS C 356
1.60A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wjt 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		4 / 5
LEU D4298
GLN C6850
THR C6846
HIS D4301
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 5
LEU C6887
THR C6891
THR C6880
HIS C6867
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
LEU C6909
ASN C6862
VAL A7094
ASN A7096
GLY C6890
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wjt NSP10
(SARS-CoV-2)		4 / 5
GLN B4306
THR B4309
THR B4300
HIS B4301
1.56A
None
None
None
FMT  B4403 (-4.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wjt NSP10
(SARS-CoV-2)		4 / 5
GLN B4306
THR B4309
THR B4300
HIS B4301
1.62A
None
None
None
FMT  B4403 (-4.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wjt NSP10
(SARS-CoV-2)		4 / 5
GLN D4306
THR D4309
THR D4300
HIS D4301
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 5
GLN C6847
THR C6993
HIS C6867
LEU C6883
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_1
(ADENOSINE KINASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
SER C6964
GLY C6962
GLY C6963
ASN C7008
GLY C7076
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_1
(ADENOSINE KINASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
SER A6964
GLY A6962
GLY A6963
ASN A7008
GLY A7076
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 5
LEU A6887
THR A6891
THR A6880
HIS A6867
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 5
LEU C6887
THR C6891
THR C6880
HIS C6867
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_B_2FAB301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		6wjt 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		5 / 12
ARG B4331
SER A6872
GLY A6879
VAL A6842
VAL A6882
1.72A18.99
None
SAH  A7102 ( 4.6A)
SAH  A7102 (-3.5A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
LEU C6887
GLY C6962
GLY C6963
ASN C7008
GLY C7076
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 5
GLN A6847
THR A6993
HIS A6867
LEU A6883
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wjt 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		4 / 5
LEU B4298
GLN A6850
THR A6846
HIS B4301
1.72A
FMT  B4403 (-4.7A)
None
None
FMT  B4403 (-4.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6wjt 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		4 / 4
ALA B4324
VAL A6876
GLY A6879
THR A6880
1.21A
None
None
SAH  A7102 (-3.5A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
LEU A6887
GLY A6962
GLY A6963
ASN A7008
GLY A7076
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wjt 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		4 / 5
LEU B4298
GLN A6850
THR A6846
HIS B4301
1.66A
FMT  B4403 (-4.7A)
None
None
FMT  B4403 (-4.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		6 / 12
LEU C6893
GLY C6871
GLY C6869
THR C6880
LEU C6883
GLY C6911
1.75A
None
SAH  C7102 (-4.4A)
SAH  C7102 (-3.8A)
None
None
FMT  C7107 ( 3.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6wjt 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		4 / 4
ALA D4324
VAL C6876
GLY C6879
THR C6880
1.22A
None
None
SAH  C7102 (-3.5A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_B_2FAB301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		6wjt 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		5 / 12
ARG D4331
SER C6872
GLY C6879
VAL C6842
VAL C6882
1.69A18.99
None
SAH  C7102 (-4.7A)
SAH  C7102 (-3.5A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
ASN C6920
ASN C6862
VAL A7094
ASN A7096
GLY C6890
1.62A
FMT  C7103 (-4.0A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wjt NSP10
(SARS-CoV-2)		4 / 5
GLN D4306
THR D4309
THR D4300
HIS D4301
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 5
LEU A6887
THR A6891
THR A6880
HIS A6867
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 5
LEU B 167
GLN B 160
THR B  57
HIS B  59
1.79A
None
None
ZN  C 201 ( 4.4A)
ZN  C 201 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 5
LEU A 167
GLN A 160
THR A  57
HIS A  59
1.72A
None
None
MES  B 201 (-4.7A)
ZN  B 202 (-2.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_D_2FAD500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
THR B 115
ASP B  82
HIS A  59
GLY B 147
PHE B 110
1.72A13.88
None
ZN  B 202 (-2.3A)
ZN  B 202 (-2.6A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 5
LEU D 167
GLN D 160
THR D  57
HIS D  59
1.72A
None
None
ZN  A 201 ( 4.4A)
ZN  A 201 (-4.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 5
LEU C 167
GLN C 160
THR C  57
HIS C  59
1.73A
None
None
ZN  D 202 ( 4.7A)
ZN  D 202 (-3.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_D_2FAD500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
THR D 115
ASP D  82
HIS C  59
GLY D 147
PHE D 110
1.79A13.88
None
ZN  D 202 (-2.7A)
ZN  D 202 (-3.2A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 5
LEU B 167
GLN B 160
THR B  57
HIS B  59
1.73A
None
None
ZN  C 201 ( 4.4A)
ZN  C 201 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 5
LEU C 167
GLN C 160
THR C  57
HIS C  59
1.67A
None
None
ZN  D 202 ( 4.7A)
ZN  D 202 (-3.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 5
LEU D 167
GLN D 160
THR D  57
HIS D  59
1.76A
None
None
ZN  A 201 ( 4.4A)
ZN  A 201 (-4.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_D_2FAD500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
THR C 115
ASP C  82
HIS B  59
GLY C 147
PHE C 110
1.79A13.88
None
ZN  C 201 (-2.4A)
ZN  C 201 (-3.3A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 5
LEU A 167
GLN A 160
THR A  57
HIS A  59
1.76A
None
None
MES  B 201 (-4.7A)
ZN  B 202 (-2.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
LEU D 159
GLY A 147
THR D  54
ASN A  75
ASP A  82
1.68A
None
None
None
None
ZN  A 201 (-2.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
LEU C6887
GLY C6962
GLY C6963
ASN C7008
GLY C7076
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wkq NSP10
(SARS-CoV-2)		4 / 5
GLN D4306
THR D4309
THR D4300
HIS D4301
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
ASN C6920
ASN C6862
VAL A7094
ASN A7096
GLY C6890
1.68A
FMT  C7106 ( 4.1A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_1
(ADENOSINE KINASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
SER C6964
GLY C6962
GLY C6963
ASN C7008
GLY C7076
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_1
(ADENOSINE KINASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
SER A6964
GLY A6962
GLY A6963
ASN A7008
GLY A7076
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wkq NSP16
(SARS-CoV-2)		4 / 5
LEU C6887
THR C6891
THR C6880
HIS C6867
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wkq NSP16
(SARS-CoV-2)		4 / 5
LEU A6887
THR A6891
THR A6880
HIS A6867
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wkq NSP16
(SARS-CoV-2)		4 / 5
GLN A6847
THR A6993
HIS A6867
LEU A6883
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wkq NSP10
(SARS-CoV-2)		4 / 5
GLN D4306
THR D4309
THR D4300
HIS D4301
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6wkq NSP10
NSP16
(SARS-CoV-2)		4 / 4
ALA D4324
VAL C6876
GLY C6879
THR C6880
1.22A
None
None
SFG  C7103 ( 3.5A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
LEU C6909
ASN C6862
VAL A7094
ASN A7096
GLY C6890
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
LEU A6887
GLY A6962
GLY A6963
ASN A7008
GLY A7076
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6wkq NSP10
NSP16
(SARS-CoV-2)		4 / 4
ALA B4324
VAL A6876
GLY A6879
THR A6880
1.21A
None
None
SFG  A7103 ( 3.5A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wkq NSP16
(SARS-CoV-2)		4 / 5
GLN C6847
THR C6993
HIS C6867
LEU C6883
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wkq NSP10
NSP16
(SARS-CoV-2)		4 / 5
LEU D4298
GLN C6850
THR C6846
HIS D4301
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wkq NSP10
NSP16
(SARS-CoV-2)		4 / 5
LEU B4298
GLN A6850
THR A6846
HIS B4301
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wkq NSP10
(SARS-CoV-2)		4 / 5
GLN B4306
THR B4309
THR B4300
HIS B4301
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wkq NSP10
(SARS-CoV-2)		4 / 5
GLN B4306
THR B4309
THR B4300
HIS B4301
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wkq NSP16
(SARS-CoV-2)		4 / 5
LEU C6887
THR C6891
THR C6880
HIS C6867
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wkq NSP16
(SARS-CoV-2)		4 / 5
LEU A6887
THR A6891
THR A6880
HIS A6867
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wkq NSP10
NSP16
(SARS-CoV-2)		4 / 5
LEU B4298
GLN A6850
THR A6846
HIS B4301
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_1
(ADENOSINE KINASE)		6wnp 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
SER A 113
ASP A 153
PHE A 305
ALA A   7
ASP A 295
1.55A23.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wnp 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
HIS A  41
LEU A  27
GLY A 146
HIS A 163
PHE A 181
1.77A19.88
U5G  A 401 (-3.3A)
U5G  A 401 ( 4.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wnp 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 5
GLN A 110
THR A 111
THR A 201
LEU A 250
1.43A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wnp 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
LEU A 205
VAL A 296
LEU A 250
ASN A 214
GLY A 215
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6wnp 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 4
ALA A 206
VAL A 261
GLY A 258
THR A 257
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_1
(ADENOSINE KINASE)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
SER A6964
GLY A6962
GLY A6963
ASN A7008
GLY A7076
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 5
LEU A6887
THR A6891
THR A6880
HIS A6867
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 5
GLN A6847
THR A6993
HIS A6867
LEU A6883
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 5
LEU A6887
THR A6891
THR A6880
HIS A6867
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
LEU A6887
GLY A6962
GLY A6963
ASN A7008
GLY A7076
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wq3 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		4 / 5
LEU B4298
GLN A6850
THR A6846
HIS B4301
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6wq3 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		4 / 4
ALA B4324
VAL A6876
GLY A6879
THR A6880
1.22A
None
None
SAH  A7101 (-3.5A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wq3 NSP10
(SARS-CoV-2)		4 / 5
GLN B4306
THR B4309
THR B4300
HIS B4301
1.60A
SO4  B4404 (-4.3A)
SO4  B4404 (-3.8A)
SO4  B4403 (-3.2A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wq3 NSP10
(SARS-CoV-2)		4 / 5
GLN B4306
THR B4309
THR B4300
HIS B4301
1.54A
SO4  B4404 (-4.3A)
SO4  B4404 (-3.8A)
SO4  B4403 (-3.2A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wqd NSP7
NSP8
(SARS-CoV-2)		4 / 5
GLN D  88
THR D  89
THR C   9
LEU C  56
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wqd NSP7
NSP8
(SARS-CoV-2)		5 / 12
LEU A  13
GLY A  64
VAL A  66
LEU A  17
GLY B 113
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_2
(ADENOSINE KINASE)		6wqd NSP8
(SARS-CoV-2)		4 / 5
LEU D 128
ILE D 132
ALA D 188
PHE D 147
1.78A16.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wqd NSP7
NSP8
(SARS-CoV-2)		5 / 12
LEU C  13
GLY C  64
VAL C  66
LEU C  17
GLY D 113
1.26A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wqd NSP7
NSP8
(SARS-CoV-2)		5 / 12
LEU C  17
GLY C  64
VAL C  66
LEU C  20
GLY D 113
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wqd NSP7
NSP8
(SARS-CoV-2)		4 / 5
GLN B  88
THR B  89
THR A   9
LEU A  56
1.48A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wqf 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
ASP A 216
GLY A 283
LEU A 287
ASN A 214
GLY A   2
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6wqf 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
LEU A 205
VAL A 296
LEU A 250
ASN A 214
GLY A 215
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6wqf 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 4
ALA A 206
VAL A 261
GLY A 258
THR A 257
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6wqf 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 5
GLN A 110
THR A 111
THR A 201
LEU A 250
1.20A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)		6wqf 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
HIS A  41
LEU A  27
GLY A 146
HIS A 163
PHE A 181
1.78A19.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6y2e REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 5
GLN A 110
THR A 111
THR A 201
LEU A 250
1.20A19.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6y2g REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
LEU B 208
GLY B 275
ASN B 277
LEU B 268
GLY B 278
1.40A19.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)		6y2g REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
HIS B  41
LEU B  27
GLY B 146
HIS B 163
PHE B 181
1.73A19.88
O6K  B 401 ( 3.7A)
None
None
O6K  B 401 ( 4.0A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
HIS A  41
LEU A  27
GLY A 146
HIS A 163
PHE A 181
1.79A14.75
None
None
None
DMS  A 405 (-3.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 4
ALA A 206
VAL A 261
GLY A 258
THR A 257
1.75A18.40
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
LEU A 205
VAL A 296
LEU A 250
ASN A 214
GLY A 215
1.67A17.33
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 5
GLN A 110
THR A 111
THR A 201
LEU A 250
1.51A14.75
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 12
LEU A  13
GLY A  64
VAL A  66
LEU A  17
GLY B 113
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 12
LEU C  17
GLY C  64
VAL C  66
LEU C  20
GLY D 113
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_2
(ADENOSINE KINASE)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		4 / 5
LEU D 128
ILE D 132
ALA D 188
PHE D 147
1.78A15.72
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		4 / 5
GLN D  88
THR D  89
THR C   9
LEU C  56
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 12
LEU C  13
GLY C  64
VAL C  66
LEU C  17
GLY D 113
1.28A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_2
(ADENOSINE KINASE)		6yla SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 5
LEU A 387
ILE A 358
ALA A 363
PHE A 338
1.70A20.74
DMS  A 905 ( 4.2A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_2
(ADENOSINE KINASE)		6ym0 SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 5
LEU E 387
ILE E 358
ALA E 363
PHE E 338
1.80A20.74
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6ynq REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 5
GLN A 110
THR A 111
THR A 201
LEU A 250
1.17A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ynq REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
LEU A 205
VAL A 296
LEU A 250
ASN A 214
GLY A 215
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)		6ynq REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
HIS A  41
LEU A  27
GLY A 146
HIS A 163
PHE A 181
1.79A19.88
None
None
None
P6N  A 502 (-3.8A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ynq REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
ASP A 216
GLY A 283
LEU A 287
ASN A 214
GLY A   2
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6ynq REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 4
ALA A 206
VAL A 261
GLY A 258
THR A 257
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		6yt8 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 5
GLN A 110
THR A 111
THR A 201
LEU A 250
1.34A
PEG  A 405 ( 3.9A)
CL  A 406 ( 3.6A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6yt8 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
ASP A 216
GLY A 283
LEU A 287
ASN A 214
GLY A   2
1.62A
None
None
PEG  A 404 (-2.9A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		6yt8 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 4
ALA A 206
VAL A 261
GLY A 258
THR A 257
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)		6yt8 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
HIS A  41
LEU A  27
GLY A 146
HIS A 163
PHE A 181
1.80A19.88
PK8  A 401 (-3.2A)
PK8  A 401 ( 3.6A)
None
DMS  A 403 (-4.1A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6yt8 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
LEU A 205
VAL A 296
LEU A 250
ASN A 214
GLY A 215
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
LEU B 126
GLY B  47
GLY B  48
ASN E 101
GLY E 103
1.25A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
LEU E 126
GLY B  47
GLY B  46
ASN E  99
GLY E 103
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ASN B  54
LEU B  88
GLY B  48
GLY B  51
ASN E 101
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ASN B  54
LEU B  88
GLY B  47
GLY B  51
ASN E 101
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ASN D 115
LEU D 122
ASN A 115
LEU D  93
GLY A  78
1.71A
EDO  D 201 (-3.6A)
None
EDO  D 201 (-3.4A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ASN E  37
LEU E  75
GLY E  47
LEU E  43
GLY E 130
1.66A
None
EPE  E 203 (-3.6A)
EPE  E 202 (-4.3A)
None
EPE  E 202 ( 4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ASN B  37
LEU B  75
GLY B  47
LEU B  43
GLY B 130
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
LEU E 109
GLY B  47
GLY B  46
VAL E 100
ASN B  40
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ASN D  37
LEU D  75
GLY D  47
LEU D  43
GLY D 130
1.66A
None
None
EDO  D 206 (-4.5A)
None
EDO  D 205 ( 4.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
GLY C  85
ASN D 159
LEU C 123
ASN D  20
ASP D 162
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_1
(ADENOSINE KINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
GLY E 133
GLY B  47
ASN E 101
ALA B  38
GLY E 103
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ASN B  54
LEU B  43
GLY E 133
GLY B  47
ASN E 101
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ASN A  37
LEU A  75
GLY A  47
LEU A  43
GLY A 130
1.62A
None
None
None
None
EDO  A 202 ( 4.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ASN B  54
LEU B  88
GLY B  48
GLY B  47
ASN E 101
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
LEU E 164
GLY E 133
ASN E 101
LEU E 126
GLY B  51
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
LEU B 127
GLY B  47
GLY B  48
ASN E 101
GLY E 103
1.14A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ASN C  37
LEU C  75
GLY C  47
LEU C  43
GLY C 130
1.67A
None
EPE  C 202 (-3.4A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
LEU B 127
GLY B  47
GLY B  48
ASN E 101
GLY E 103
1.23A
None
APR  B 201 (-3.6A)
APR  B 201 (-3.5A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ASN B  40
GLY B  47
GLY B  46
LEU B  43
GLY E 130
1.54A
APR  B 201 (-3.8A)
APR  B 201 (-3.6A)
EDO  B 202 (-3.9A)
None
APR  E 201 (-3.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
GLY C  85
ASN D 159
LEU C 123
ASN D  20
ASP D 162
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
LEU B 127
GLY B  46
GLY B  47
ASN E 101
GLY E 103
1.42A
None
EDO  B 202 (-3.9A)
APR  B 201 (-3.6A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ASN A  54
LEU A  88
GLY A  47
GLY A  51
VAL A  49
1.62A
None
None
APR  A 201 (-4.1A)
None
APR  A 201 (-3.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_1
(ADENOSINE KINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
GLY E 133
GLY B  46
ASN E 101
ALA B  38
GLY E 103
1.63A
None
EDO  B 202 (-3.9A)
None
APR  B 201 (-3.4A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
LEU B 126
GLY B  47
GLY B  48
ASN E 101
GLY E 103
1.30A
APR  B 201 (-4.7A)
APR  B 201 (-3.6A)
APR  B 201 (-3.5A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_1
(ADENOSINE KINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
GLY E 133
GLY B  47
ASN E 101
ALA B  38
GLY E 103
1.58A
None
APR  B 201 (-3.6A)
None
APR  B 201 (-3.4A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
LEU E 109
GLY B  47
GLY B  46
VAL E 100
ASN B  40
1.56A
None
APR  B 201 (-3.6A)
EDO  B 202 (-3.9A)
None
APR  B 201 (-3.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ASN B  40
GLY B  51
GLY B  46
LEU B  43
GLY E 130
1.61A
APR  B 201 (-3.8A)
None
EDO  B 202 (-3.9A)
None
APR  E 201 (-3.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ASN E  54
LEU E  88
GLY E  47
GLY E  51
VAL E  49
1.67A
None
None
APR  E 201 (-4.4A)
None
APR  E 201 (-3.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ASN D  54
LEU D  88
GLY D  47
GLY D  51
VAL D  49
1.68A
None
None
APR  D 201 ( 4.3A)
None
APR  D 201 (-3.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
LEU E 126
GLY B  47
GLY B  46
ASN E  99
GLY E 103
1.48A
APR  E 201 (-4.7A)
APR  B 201 (-3.6A)
EDO  B 202 (-3.9A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ASN D 115
LEU D 122
ASN A 115
LEU D  93
GLY A  78
1.69A
EDO  A 207 ( 3.7A)
None
EDO  A 207 (-3.9A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ASN B  37
LEU B  75
GLY B  47
LEU B  43
GLY B 130
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		7bqy MAIN PROTEASE
(SARS-CoV-2)		4 / 5
GLN A 110
THR A 111
THR A 201
LEU A 250
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		7bqy MAIN PROTEASE
(SARS-CoV-2)		5 / 12
LEU A 205
VAL A 296
LEU A 250
ASN A 214
GLY A 215
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		7bqy MAIN PROTEASE
(SARS-CoV-2)		4 / 4
ALA A 206
VAL A 261
GLY A 258
THR A 257
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_A_2FAA301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		7btf NSP12
(SARS-CoV-2)		5 / 11
MET A 666
SER A 343
GLY A 345
VAL A 535
VAL A 354
1.57A13.84
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_B_2FAB301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		7btf NSP12
(SARS-CoV-2)		5 / 12
ARG A 392
SER A 672
VAL A 667
SER A 397
VAL A 675
1.75A13.84
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		7btf NSP12
(SARS-CoV-2)		4 / 4
ALA A 777
VAL A 764
GLY A 616
THR A 801
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		7btf NSP12
NSP8
(SARS-CoV-2)		5 / 12
LEU A 366
VAL A 373
LEU B  91
ASN A 356
GLY A 345
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		7btf NSP7
NSP8
(SARS-CoV-2)		5 / 12
ASN D 109
LEU D 128
GLY D 113
VAL D 131
GLY C  64
1.29A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		7btf NSP7
NSP8
(SARS-CoV-2)		4 / 5
GLN D  88
THR D  89
THR C   9
LEU C  56
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_2
(ADENOSINE KINASE)		7btf NSP7
(SARS-CoV-2)		4 / 4
ALA C  48
VAL C  53
PHE C  49
THR C   9
1.66A11.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_1
(ADENOSINE KINASE)		7btf NSP12
(SARS-CoV-2)		5 / 12
SER A 592
GLY A 596
GLY A 597
ASN A 600
GLN A 932
1.72A16.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_2
(ADENOSINE KINASE)		7btf NSP12
(SARS-CoV-2)		4 / 5
LEU A 514
ALA A 502
MET A 519
PHE A 506
1.55A17.65
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		7btf NSP12
(SARS-CoV-2)		5 / 12
LEU A 245
GLY A 214
ASN A 215
LEU A 186
ASP A 211
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		7btf NSP12
(SARS-CoV-2)		5 / 12
LEU A 727
GLY A 712
ASN A 713
LEU A 707
ASN A  39
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_1
(ADENOSINE KINASE)		7btf NSP12
(SARS-CoV-2)		5 / 12
SER A 592
GLY A 596
GLY A 597
ASN A 600
GLN A 932
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		7buy VIRUS MAIN PROTEASE
(SARS-CoV-2)		4 / 5
GLN A 110
THR A 111
THR A 201
LEU A 250
1.25A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)		7buy VIRUS MAIN PROTEASE
(SARS-CoV-2)		5 / 12
HIS A  41
LEU A  27
GLY A 146
HIS A 163
PHE A 181
1.76A19.88
JRY  A 401 (-3.9A)
None
None
DMS  A 402 (-3.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		7buy VIRUS MAIN PROTEASE
(SARS-CoV-2)		4 / 4
ALA A 206
VAL A 261
GLY A 258
THR A 257
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		7buy VIRUS MAIN PROTEASE
(SARS-CoV-2)		5 / 12
LEU A 205
VAL A 296
LEU A 250
ASN A 214
GLY A 215
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		7buy VIRUS MAIN PROTEASE
(SARS-CoV-2)		5 / 12
ASP A 216
GLY A 283
LEU A 287
ASN A 214
GLY A   2
1.66A
None
DMS  A 404 ( 4.5A)
None
None
DMS  A 404 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_1
(ADENOSINE KINASE)		7bv1 NSP12
(SARS-CoV-2)		5 / 12
ASP A 135
GLY A 137
ASN A 138
PHE A 134
ASP A 140
1.75A16.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		7bv1 NSP7
NSP8
(SARS-CoV-2)		4 / 5
GLN D  88
THR D  89
THR C   9
LEU C  56
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		7bv1 NSP12
(SARS-CoV-2)		5 / 12
GLY A 352
ASN A 314
VAL A 354
LEU A 329
ASN A 300
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_2
(ADENOSINE KINASE)		7bv1 NSP12
(SARS-CoV-2)		4 / 5
LEU A 514
ALA A 502
MET A 519
PHE A 506
1.67A17.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_B_2FAB301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		7bv1 NSP12
(SARS-CoV-2)		5 / 12
ARG A 392
SER A 672
VAL A 667
SER A 397
VAL A 675
1.75A13.93
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_A_2FAA301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		7bv1 NSP12
(SARS-CoV-2)		5 / 11
MET A 666
SER A 343
GLY A 345
VAL A 535
VAL A 354
1.57A13.93
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_2
(ADENOSINE KINASE)		7bv1 NSP7
(SARS-CoV-2)		4 / 4
ALA C  48
VAL C  53
PHE C  49
THR C   9
1.64A11.96
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		7bv1 NSP12
NSP8
(SARS-CoV-2)		5 / 12
LEU A 366
VAL A 373
LEU B  91
ASN A 356
GLY A 345
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_1
(ADENOSINE KINASE)		7bv2 NSP12
NSP8
(SARS-CoV-2)		5 / 12
SER A 384
GLY A 385
ASN A 386
MET B  94
ALA A 382
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_2
(ADENOSINE KINASE)		7bv2 NSP7
(SARS-CoV-2)		4 / 4
ALA C  48
VAL C  53
PHE C  49
THR C   9
1.74A11.96
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_2
(ADENOSINE KINASE)		7bv2 NSP12
(SARS-CoV-2)		4 / 5
LEU A 514
ALA A 502
MET A 519
PHE A 506
1.60A17.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_1
(ADENOSINE KINASE)		7bv2 NSP12
(SARS-CoV-2)		5 / 12
GLY A 683
GLY A 559
GLN A 541
GLN A 408
GLY A 503
1.80A
 U  T  10 ( 3.1A)
U  T  10 ( 3.5A)
U  T   8 ( 3.4A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		7bv2 NSP12
(SARS-CoV-2)		4 / 5
GLN A 210
THR A 123
THR A 148
LEU A 178
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		7bv2 NSP12
NSP8
(SARS-CoV-2)		5 / 12
LEU A 366
VAL A 373
LEU B  91
ASN A 356
GLY A 345
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		7bv2 NSP12
(SARS-CoV-2)		4 / 4
ALA A 660
VAL A 662
GLY A 559
THR A 540
1.70A
None
None
U  T  10 ( 3.5A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)		7bv2 NSP12
(SARS-CoV-2)		5 / 12
ASP A 477
LEU A 638
LEU A 575
GLY A 485
HIS A 642
1.78A20.69
None
None
None
None
ZN  A1002 (-3.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_2
(ADENOSINE KINASE)		7bv2 NSP12
(SARS-CoV-2)		4 / 4
ALA A 777
VAL A 764
GLY A 616
THR A 801
1.68A
None
None
MG  A1005 ( 4.6A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_1
(ADENOSINE KINASE)		7bv2 NSP12
NSP8
(SARS-CoV-2)		5 / 12
SER A 384
GLY A 385
ASN A 386
MET B  94
ALA A 382
1.73A16.37
None